Agilon Health, Inc. $AGL Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. reduced its stake in Agilon Health by 2.7%, selling 826,647 shares and now holding approximately 30.3 million shares valued at $131.1 million.
• Several analysts have downgraded their target prices for Agilon Health, with Benchmark lowering it from $4.00 to $1.50 and Jefferies reducing theirs from $2.40 to $1.10.
• Agilon Health reported a loss of ($0.25) per share in its latest earnings, missing the consensus estimate and experiencing a 5.9% revenue decline compared to the previous year.

Vanguard Group Inc. cut its position in shares of Agilon Health, Inc. (NYSE:AGL - Free Report) by 2.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 30,285,760 shares of the company's stock after selling 826,647 shares during the period. Vanguard Group Inc. owned 7.33% of Agilon Health worth $131,137,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the stock. Millennium Management LLC raised its position in Agilon Health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares during the period. Northern Trust Corp raised its position in Agilon Health by 13.0% during the fourth quarter. Northern Trust Corp now owns 2,962,350 shares of the company's stock worth $5,628,000 after acquiring an additional 340,304 shares during the period. Algert Global LLC raised its position in Agilon Health by 1,042.7% during the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock worth $4,007,000 after acquiring an additional 1,924,157 shares during the period. Two Sigma Investments LP raised its position in Agilon Health by 73.7% during the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock worth $1,630,000 after acquiring an additional 363,855 shares during the period. Finally, Susquehanna Fundamental Investments LLC acquired a new position in Agilon Health during the fourth quarter worth $1,616,000.

Wall Street Analyst Weigh In

AGL has been the subject of a number of research analyst reports. The Goldman Sachs Group upped their price objective on shares of Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Wells Fargo & Company reduced their price objective on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, May 13th. Benchmark reduced their price objective on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a research report on Wednesday, August 6th. Barclays reduced their price objective on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a research report on Wednesday, August 6th. Finally, Evercore ISI reduced their target price on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Four equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Agilon Health currently has an average rating of "Hold" and a consensus price target of $3.07.

Agilon Health Stock Performance

Shares of NYSE AGL traded up $0.08 during mid-day trading on Wednesday, reaching $1.31. The company's stock had a trading volume of 5,105,334 shares, compared to its average volume of 22,827,828. The stock has a 50-day moving average of $1.81 and a two-hundred day moving average of $2.94. The stock has a market capitalization of $540.82 million, a P/E ratio of -1.69 and a beta of 0.14. Agilon Health, Inc. has a 1-year low of $0.71 and a 1-year high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The business had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. Agilon Health's quarterly revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the company earned ($0.07) earnings per share. Analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.